FERTICANNCT07148141
Impact of Breast Cancer on Human Folliculogenesis
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
Version history last read from ClinicalTrials.gov on Aug 30, 2026. The record was updated there on Nov 20, 2026; versions filed since then are not listed here yet.
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Trial completed
- Study completion date changed from estimate of Aug 31, 2027 to Aug 31, 2026
- Minor Study completion date: Aug 31, 2025 to Aug 31, 2027v2
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Fertility preservation for patients with breast cancer: Altered response to ovarian stimulation and loss of cholesterol homeostasis in ovarian follicles
Timeframe: 65 months
Secondary (8)
Assessment of Anti-Mullerian Hormone levels
Assessment of antral follicle count
Total dose of FSH administered
Number of harvested oocytes
Oocyte maturity
Show 3 moreShow less
Oocyte atresia
Impact of breast cancer on enzymes and regulators of the cholesterol biosynthetic pathway
Quantification of cholesterol and its intermediates in follicular fluids of Breast Cancer patients and Oocytes Donors
Arms and interventions
Breast cancer patients (BC)
Breast cancer subgroups (Triple-negative breast cancer (TN), Hormone-dependent breast cancer (HR+), HER2-amplified breast cancer (HER2+))
Oocyte donors (OD)
Healthy women
Other: Ovarian stimulation
Sites
1 site in 1 country
- CHU Clermont-FerrandClermont-Ferrand, Auvergne Rhones-Alpes, France